TR201706038T4 - Diklofenak formülasyonları ve kullanım yöntemleri. - Google Patents
Diklofenak formülasyonları ve kullanım yöntemleri. Download PDFInfo
- Publication number
- TR201706038T4 TR201706038T4 TR2017/06038T TR201706038T TR201706038T4 TR 201706038 T4 TR201706038 T4 TR 201706038T4 TR 2017/06038 T TR2017/06038 T TR 2017/06038T TR 201706038 T TR201706038 T TR 201706038T TR 201706038 T4 TR201706038 T4 TR 201706038T4
- Authority
- TR
- Turkey
- Prior art keywords
- methods
- formulations
- diclofenac
- acute pain
- diclofenac formulations
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001259 diclofenac Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 abstract 3
- 208000005298 acute pain Diseases 0.000 abstract 3
- 208000019695 Migraine disease Diseases 0.000 abstract 2
- 206010027599 migraine Diseases 0.000 abstract 2
- 206010054956 Phonophobia Diseases 0.000 abstract 1
- 206010034960 Photophobia Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Yöntemler ve formülasyonlar, akut ağrıdan hızlı ve sürekli hafifleme sağlayan diklofenak ve diklofenak formülasyonları kullanılarak migrenin ve diğer akur ağrı adımlarının tedavi edilmesi için sağlanmaktadır. Yöntemler ve formülasyonlar ayrıca genelde migrene ve fotofobi, fonofobi, bulantı ve kusma gibi akut bir ağrıya eşlik eden semptomların tedavi edilmesi için sağlanmaktadır.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69202405P | 2005-06-17 | 2005-06-17 | |
US69175705P | 2005-06-17 | 2005-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201706038T4 true TR201706038T4 (tr) | 2019-02-21 |
Family
ID=37396065
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/06038T TR201706038T4 (tr) | 2005-06-17 | 2006-06-16 | Diklofenak formülasyonları ve kullanım yöntemleri. |
Country Status (24)
Country | Link |
---|---|
US (7) | US7759394B2 (tr) |
EP (4) | EP3103441B1 (tr) |
KR (1) | KR101352130B1 (tr) |
CN (3) | CN101272768A (tr) |
AR (1) | AR057378A1 (tr) |
AU (1) | AU2006257072B2 (tr) |
BR (1) | BRPI0612245A2 (tr) |
CA (2) | CA2932603C (tr) |
EC (1) | ECSP077989A (tr) |
ES (3) | ES2717879T3 (tr) |
GT (1) | GT200600261A (tr) |
HK (1) | HK1213814A1 (tr) |
JO (1) | JO3352B1 (tr) |
MX (1) | MX2007016072A (tr) |
NO (1) | NO342336B1 (tr) |
NZ (1) | NZ564002A (tr) |
PE (1) | PE20070074A1 (tr) |
PL (1) | PL1890680T3 (tr) |
PT (1) | PT1890680T (tr) |
RU (1) | RU2432160C2 (tr) |
TR (1) | TR201706038T4 (tr) |
TW (1) | TW200740470A (tr) |
WO (1) | WO2006133954A2 (tr) |
ZA (1) | ZA200710858B (tr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
US7700125B2 (en) * | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
NZ579972A (en) * | 2007-05-24 | 2012-03-30 | Novartis Ag | Oral dosage form of diclofenac providing fast absorption of drug |
CN103932988A (zh) | 2009-04-24 | 2014-07-23 | 伊休蒂卡有限公司 | 吲哚美辛的新剂型 |
NZ595987A (en) | 2009-04-24 | 2014-02-28 | Iceutica Pty Ltd | A novel formulation of diclofenac |
EP2480212B1 (en) * | 2009-09-25 | 2016-07-06 | Novartis Consumer Health S.A. | Oral pharmaceutical composition comprising diclofenac |
FR2984165B1 (fr) * | 2011-12-16 | 2014-06-27 | Pharmeuro | Traitement des crises de migraines, notamment d'algies vasculaires de la face |
US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
US9855234B2 (en) | 2014-07-08 | 2018-01-02 | Insys Development Company, Inc. | Diclofenac sublingual spray |
CN106580886A (zh) * | 2016-12-05 | 2017-04-26 | 北京万全德众医药生物技术有限公司 | 一种双氯芬酸钾散剂及其制备方法 |
WO2019030773A1 (en) * | 2017-08-10 | 2019-02-14 | Sarudbhava Formulations Private Limited | DICLOFENAC COMPOSITIONS WITH LOW DOSE |
US11260026B2 (en) | 2018-12-14 | 2022-03-01 | Apr Applied Pharma Research Sa | Ready to use diclofenac stick packs |
KR20230022941A (ko) | 2020-06-10 | 2023-02-16 | 에이피알 어플라이드 파르마 리서어치 에스.에이. | 생체이용성 당-기반 디클로페낙 제형 |
EP3928766A1 (en) | 2020-06-26 | 2021-12-29 | Usso Barnas | Pharmaceutical composition and use thereof |
CN115317464B (zh) * | 2022-09-01 | 2023-08-08 | 苏州弘森药业股份有限公司 | 一种双氯芬酸钾微胶囊及其制备方法 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3558690A (en) * | 1965-04-08 | 1971-01-26 | Gelgy Chemical Corp | Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation |
US4344929A (en) * | 1980-04-25 | 1982-08-17 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
JPS57191962A (en) | 1981-05-20 | 1982-11-25 | Hitachi Ltd | Fuel cell |
IT1209667B (it) * | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
CH673395A5 (tr) * | 1987-01-30 | 1990-03-15 | Ciba Geigy Ag | |
US5211957A (en) * | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
IT1226549B (it) | 1988-07-12 | 1991-01-24 | Resa Farma | Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose. |
GB8824392D0 (en) | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
GB8920693D0 (en) | 1989-09-13 | 1989-10-25 | Nicholas Kiwi Pty Ltd | Non-effervescent ibuprofen compositions |
DE59105562D1 (de) | 1990-06-28 | 1995-06-29 | Ciba Geigy Ag | Alpha-Carbonylphenylacetonitrilderivate als Stabilisatoren für organische Materialien. |
EP0466650A2 (en) | 1990-07-11 | 1992-01-15 | Warner-Lambert Company | Improvements in non-steroidal anti-inflammatory therapy |
MX9300110A (es) * | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
ES2173096T3 (es) * | 1992-08-05 | 2002-10-16 | Faulding F H & Co Ltd | Composicion farmaceutica peletizada. |
IT1264696B1 (it) | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
EP0642784B1 (de) * | 1993-09-07 | 1999-05-19 | Gerhard Dr. Gergely | Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
CA2190598A1 (en) | 1994-05-27 | 1995-12-07 | Lawrence John Penkler | Pharmaceutical composition |
ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
IT1283029B1 (it) * | 1996-05-17 | 1998-04-03 | Resa Farma | Composizioni farmaceutiche a base di diclofenac |
DE19538555A1 (de) | 1995-10-17 | 1997-04-24 | Beiersdorf Ag | Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen |
EP0893992B1 (en) * | 1996-04-16 | 2004-03-03 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
US7687542B2 (en) * | 1996-05-17 | 2010-03-30 | Kowa Pharmaeuticals America, Inc. | Rapidly bioavailable tablet and capsule formulations of diclofenac |
US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
US20060013896A1 (en) * | 1996-05-17 | 2006-01-19 | Giorgio Reiner | Methods of treating acute pain using diclofenac |
US5854279A (en) * | 1996-06-04 | 1998-12-29 | Eisai Co., Ltd | Therapeutic agent for dermatosis |
US5914129A (en) | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
US5788987A (en) | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
US6365180B1 (en) * | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
EP1109534B1 (en) | 1998-09-10 | 2003-02-12 | Nycomed Danmark A/S | Quick release pharmaceutical compositions of drug substances |
EP1312355B1 (en) * | 2001-11-20 | 2003-06-11 | Apr Applied Pharma Research S.A. | Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs |
MXPA05011343A (es) * | 2003-05-08 | 2005-12-12 | Nektar Therapeutics Uk Ltd | Materiales particulados. |
JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
US7939561B2 (en) * | 2006-02-07 | 2011-05-10 | Apr Applied Pharma Research S.A. | Blister packaging for acute pain regimens |
US7700125B2 (en) * | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
-
2006
- 2006-06-11 JO JOP/2006/0177A patent/JO3352B1/ar active
- 2006-06-12 TW TW095120788A patent/TW200740470A/zh unknown
- 2006-06-16 ES ES13181615T patent/ES2717879T3/es active Active
- 2006-06-16 CN CNA2006800296269A patent/CN101272768A/zh active Pending
- 2006-06-16 PT PT67431676T patent/PT1890680T/pt unknown
- 2006-06-16 RU RU2008101784/15A patent/RU2432160C2/ru active
- 2006-06-16 AU AU2006257072A patent/AU2006257072B2/en active Active
- 2006-06-16 NZ NZ564002A patent/NZ564002A/en unknown
- 2006-06-16 CN CN202011532717.2A patent/CN112755014A/zh active Pending
- 2006-06-16 CA CA2932603A patent/CA2932603C/en active Active
- 2006-06-16 GT GT200600261A patent/GT200600261A/es unknown
- 2006-06-16 MX MX2007016072A patent/MX2007016072A/es active IP Right Grant
- 2006-06-16 US US11/455,120 patent/US7759394B2/en active Active
- 2006-06-16 TR TR2017/06038T patent/TR201706038T4/tr unknown
- 2006-06-16 ES ES16157175T patent/ES2912897T3/es active Active
- 2006-06-16 CN CN201510144782.0A patent/CN104856959A/zh active Pending
- 2006-06-16 CA CA2632375A patent/CA2632375C/en active Active
- 2006-06-16 EP EP16157175.7A patent/EP3103441B1/en active Active
- 2006-06-16 WO PCT/EP2006/005799 patent/WO2006133954A2/en active Application Filing
- 2006-06-16 KR KR1020087001172A patent/KR101352130B1/ko active IP Right Grant
- 2006-06-16 BR BRPI0612245-0A patent/BRPI0612245A2/pt not_active Application Discontinuation
- 2006-06-16 EP EP06743167.6A patent/EP1890680B1/en active Active
- 2006-06-16 PL PL06743167T patent/PL1890680T3/pl unknown
- 2006-06-16 ES ES06743167.6T patent/ES2641889T3/es active Active
- 2006-06-16 PE PE2006000678A patent/PE20070074A1/es not_active Application Discontinuation
- 2006-06-16 EP EP11001797.7A patent/EP2402003B1/en active Active
- 2006-06-16 EP EP13181615.9A patent/EP2705837B1/en active Active
- 2006-06-20 AR ARP060102600A patent/AR057378A1/es unknown
-
2007
- 2007-12-07 EC EC2007007989A patent/ECSP077989A/es unknown
- 2007-12-13 ZA ZA200710858A patent/ZA200710858B/xx unknown
-
2008
- 2008-01-17 NO NO20080352A patent/NO342336B1/no unknown
-
2009
- 2009-03-06 US US12/399,175 patent/US20090197961A1/en not_active Abandoned
-
2010
- 2010-01-07 US US12/683,517 patent/US8097651B2/en active Active
-
2013
- 2013-01-16 US US13/742,871 patent/US8927604B2/en active Active
-
2014
- 2014-11-06 US US14/534,428 patent/US9827197B2/en active Active
-
2016
- 2016-02-22 HK HK16101926.9A patent/HK1213814A1/zh unknown
-
2017
- 2017-05-24 US US15/604,479 patent/US20170319484A1/en not_active Abandoned
-
2019
- 2019-12-17 US US16/716,511 patent/US20200323776A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR201706038T4 (tr) | Diklofenak formülasyonları ve kullanım yöntemleri. | |
CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
NL301145I2 (nl) | Tirbanibulin | |
CY1118062T1 (el) | Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης | |
CR9869A (es) | Compuestos activos en ppar | |
EA201070518A1 (ru) | Композиция по уходу за волосами | |
HK1139928A1 (en) | 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as herbicides | |
BRPI0513149A (pt) | uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituìdas no tratamento de náuseas e vÈmito | |
TR200906329T1 (tr) | Kanser Hastalarında Kemik Gelişimini Desteklemek için A | |
MX2009004986A (es) | Metodos de tratamiento de anemia hemolitica. | |
DK1682530T3 (da) | Pyrrolsubstituerede indoler som inhibitorer af PAI-1 | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
EA201000491A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
MX2008007307A (es) | Granulos/capsulas modificados que contienen ingrediente activo. | |
TW200738263A (en) | ANG2 and VEGF inhibitor combinations | |
ECSP088676A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
EA200701439A1 (ru) | Pyy-агонисты и их применение | |
EA201000888A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов | |
NO20076347L (no) | Nye regimer for orale monofasiske befruktningshindrene midler | |
EA201170252A1 (ru) | Амидофеноксиндазолы в качестве ингибиторов c-мет | |
EA200900344A1 (ru) | Циклические ингибиторы 11-бета-гидроксистероиддегидрогеназы типа i | |
EA200801430A1 (ru) | Производные триазола | |
CY1113309T1 (el) | Συνθεσεις και μεθοδοι χρησιμοποιωντας αντι-cs1 αντισωματα για να θεραπευεται πολλαπλο μυελωμα | |
EA200801413A1 (ru) | Гетероциклические сетр ингибиторы |